Immunotherapy Before Surgery Might Boost Pancreatic Cancer Survival
MONDAY, April 8, 2024 (HealthDay News) — Pancreatic cancer patients may do better if they receive an immunotherapy drug as well as chemotherapy in preparation for surgery, new research suggests. Pancreatic cancer is one of the toughest to treat. Only 12% of patients live more than five years after diagnosis.Continue Reading